about
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signatureHuman-animal chimeras: ethical issues about farming chimeric animals bearing human organsAllogenic banking of dental pulp stem cells for innovative therapeuticsHuman cumulus cells molecular signature in relation to oocyte nuclear maturity stageCharacterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation.Combining DGE and RNA-sequencing data to identify new polyA+ non-coding transcripts in the human genomeCorrelating global gene regulation to angiogenesis in the developing chick extra-embryonic vascular system.A gene expression signature shared by human mature oocytes and embryonic stem cells.APRIL is overexpressed in cancer: link with tumor progressionExpression map of the human exome in CD34+ cells and blood cells: increased alternative splicing in cell motility and immune response genes.Distinct transcriptome expression of the temporal cortex of the primate Microcebus murinus during brain aging versus Alzheimer's disease-like pathology.Gene expression profile of human endometrial receptivity: comparison between natural and stimulated cycles for the same patients.[Human embryonic stem cells: from the human embryo transgressed to the regenerative medicine of tomorrow].Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applications.Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state.Topoisomerase I suppresses genomic instability by preventing interference between replication and transcriptionInsights into human endometrial receptivity from transcriptomic and proteomic data.Dynamic changes in gene expression during human early embryo development: from fundamental aspects to clinical applicationsProof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient.Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency.Genome Editing and Dialogic Responsibility: "What's in a Name?".Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas.Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase.Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myelomaEmbryonic stem cells or induced pluripotent stem cells? A DNA integrity perspective.Human cumulus cells as biomarkers for embryo and pregnancy outcomes.Involvement of BCL2 family members in the regulation of human oocyte and early embryo survival and death: gene expression and beyond.Identifying new human oocyte marker genes: a microarray approach.An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterizationAn inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis.Side scatter intensity is highly heterogeneous in undifferentiated pluripotent stem cells and predicts clonogenic self-renewal.Human induced pluripotent stem cells: A disruptive innovation.Temporal analysis of genome alterations induced by single-cell passaging in human embryonic stem cells.Long non-coding RNAs in human early embryonic development and their potential in ART.Induction of angiogenesis by normal and malignant plasma cells.Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes.Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.
P50
Q24647037-1DAB06E5-404E-4CD4-A698-D5735B6FF58DQ26746095-220E152D-DA1D-4990-82C6-E11BEEE1054AQ26795542-91A840AE-78F8-4194-863D-E4C2BF10109FQ28743070-EE360DFD-A14D-4BA7-9ED5-DE93292FF937Q30485147-CD8A6F3A-6791-49FE-939B-05D5481426F4Q30720040-F9EA261A-4D36-4783-8B96-0580403286D0Q30896248-F1B00542-4AED-417A-9B2D-F87D8B59D55CQ33398202-9E9D7FBB-9542-4D96-BD34-C697FBDDF3CBQ33418752-525AB1CD-D1EB-4779-9A66-2D424DDCB560Q33529054-0AD959CF-78B4-496B-B5BC-F32FEB8A20C6Q33529054-9A58FD11-CF53-49DC-A6DB-F3CCF9460925Q33700468-13742E00-F635-420B-B6D5-8FCC0DF9B0E0Q33700468-14710A5B-0CC7-40D8-B6AB-EC05E7109754Q33856573-26EE56FA-7457-4310-A2D9-9A55EF3F67DBQ34018411-B9F5D71B-8517-485A-A1CA-E86347304240Q34022979-58F781B9-A945-49DB-9092-0BBA493F3D3FQ34029292-BEF52E8A-C01B-47AE-8ADF-AD430240A0B3Q34031653-2E3C20D7-1BE9-44E7-90BC-593A75C6E13DQ34084192-609A14F8-FA6B-4C1E-A620-D3D5CC4B3B05Q34131722-E1A4B1F8-AB66-4A37-9A5B-2CACA472E0EAQ35184151-153EFAD9-EA0E-4A0C-9523-9805D1E67FA4Q35775443-CFAA0C28-6ABB-46C5-BD3F-ACCD7EED9C3BQ35859711-D313E428-612C-4C20-9045-930390086EF7Q35866406-5C8586EE-F0A6-49E9-A046-460338BE94F7Q35868530-E527D2C2-CB95-4F9E-BAB2-BBA4FF744A6CQ36711639-10A8F854-C734-4825-90D5-50398F32AA13Q37125395-4B6A225B-091A-4F6F-99FB-0B29AF6E9935Q37237509-E4BEDDEF-BD48-4BA7-9642-D0CB6ED09DA5Q37627420-ED448901-D49F-4CF9-B92B-D00466F550E7Q37740724-55E4C77E-A5D2-43C5-AE73-5C6FD73AEE44Q37845593-19C9A850-6C13-43CE-80FC-69FA8229BCFFQ38304751-5E5B259B-A310-4440-BD10-193C0F3E5B8CQ38349476-65A3C60E-ADA1-4769-B34A-340905BD9B9CQ38518964-6A78CF62-7909-4A0E-A95A-26397959184AQ38577052-A8237247-45F7-426F-91D9-F370B47D7CBCQ38868682-7B22752D-6DF8-49BF-B525-B3C4483C682AQ38953436-D0CEEB1E-FDFA-4EBC-B457-1E5A76A01E45Q38961358-0BB42E06-C00D-472C-BC52-BE3E887D208FQ39870744-29DBA517-417F-431C-A7E1-A78092AE31F6Q40195952-EAF95986-7737-4DD5-A63D-32624CF0F044
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John De Vos
@ast
John De Vos
@en
John De Vos
@es
John De Vos
@nl
type
label
John De Vos
@ast
John De Vos
@en
John De Vos
@es
John De Vos
@nl
prefLabel
John De Vos
@ast
John De Vos
@en
John De Vos
@es
John De Vos
@nl
P106
P1153
7005020496
P31
P496
0000-0003-1880-4130